HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhonggui He Selected Research

Liver Neoplasms (Liver Cancer)

12/2016Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB0,+-mediated tumor targeting of liposomes for docetaxel delivery for hepatocarcinoma therapy.
9/2016Transporter-targeted cholic acid-cytarabine conjugates for improved oral absorption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhonggui He Research Topics

Disease

160Neoplasms (Cancer)
05/2024 - 11/2009
30Breast Neoplasms (Breast Cancer)
01/2023 - 11/2009
18Neoplasm Metastasis (Metastasis)
01/2023 - 01/2017
8Hypoxia (Hypoxemia)
01/2023 - 07/2017
5Melanoma (Melanoma, Malignant)
11/2023 - 12/2021
4Triple Negative Breast Neoplasms
01/2023 - 05/2020
4Hemorrhage
01/2023 - 09/2014
4Prostatic Neoplasms (Prostate Cancer)
11/2022 - 01/2018
3Inflammation (Inflammations)
11/2023 - 01/2022
3Thrombosis (Thrombus)
01/2023 - 10/2020
3Circulating Neoplastic Cells
10/2021 - 01/2019
3Hypertension (High Blood Pressure)
09/2021 - 12/2009
3Cardiotoxicity
01/2021 - 05/2020
2Hyperthermia
04/2024 - 09/2021
2Diabetic Nephropathies (Diabetic Nephropathy)
02/2024 - 01/2020
2Pain (Aches)
11/2023 - 04/2023
2Cytokine Release Syndrome
09/2023 - 01/2022
2Infections
12/2022 - 01/2019
2Colonic Neoplasms (Colon Cancer)
01/2022 - 11/2017
2Rheumatoid Arthritis
01/2022 - 11/2021

Drug/Important Bio-Agent (IBA)

56ProdrugsIBA
04/2024 - 11/2014
23Liposomes (Liposome)IBA
05/2023 - 05/2016
18Paclitaxel (Taxol)FDA LinkGeneric
01/2023 - 05/2014
17DisulfidesIBA
04/2024 - 10/2014
14Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 06/2012
131-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2023 - 06/2018
11Glutathione (Reduced Glutathione)IBA
11/2023 - 01/2019
11Docetaxel (Taxotere)FDA Link
01/2021 - 05/2016
10Reactive Oxygen Species (Oxygen Radicals)IBA
05/2024 - 01/2019
10SolutionsIBA
05/2024 - 10/2012
10Photosensitizing Agents (Photosensitizers)IBA
01/2023 - 09/2018
10AlbuminsIBA
07/2021 - 11/2009
6Therapeutic UsesIBA
12/2022 - 08/2014
6Amino Acid Transport Systems (Amino Acid Transporter)IBA
09/2020 - 05/2016
5Proteins (Proteins, Gene)FDA Link
05/2024 - 02/2012
5Mitoxantrone (Novantrone)FDA LinkGeneric
03/2024 - 02/2012
5EnzymesIBA
02/2024 - 01/2018
5Antineoplastic Agents (Antineoplastics)IBA
02/2024 - 06/2012
5Sulfides (Thioethers)IBA
01/2023 - 01/2016
5Nanoparticle Drug Delivery SystemIBA
02/2022 - 01/2016
5maleimideIBA
10/2018 - 01/2018
5Succinic Acid (Succinate)IBA
05/2016 - 06/2012
4AntigensIBA
10/2023 - 01/2018
4CamptothecinIBA
04/2023 - 02/2019
4PlatinumIBA
01/2023 - 11/2015
4Polymethyl Methacrylate (Sol)IBA
08/2016 - 02/2012
4tocophersolanIBA
05/2016 - 06/2012
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2016 - 12/2010
3NanovaccinesIBA
10/2023 - 11/2022
3Albumin-Bound PaclitaxelFDA Link
12/2022 - 11/2009
3Immune Checkpoint InhibitorsIBA
12/2022 - 09/2021
3NanogelsIBA
12/2022 - 01/2022
3LipidsIBA
11/2022 - 02/2012
3pyropheophorbide aIBA
03/2022 - 01/2020
3DipeptidesIBA
02/2022 - 02/2019
32- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
02/2022 - 02/2019
3Cytarabine (Cytosar-U)FDA LinkGeneric
01/2022 - 09/2016
3MetalsIBA
01/2022 - 02/2021
3Irinotecan (Camptosar)FDA LinkGeneric
10/2021 - 12/2019
3liposomal doxorubicin (Doxil)FDA Link
02/2021 - 05/2020
3LigandsIBA
09/2020 - 01/2018
3Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 08/2014
3Amino AcidsFDA Link
01/2017 - 12/2016
3Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
12/2016 - 06/2012
3Lysine (L-Lysine)FDA Link
12/2016 - 10/2012
3Tocopherols (Tocopherol)IBA
05/2016 - 10/2012
2nasIBA
05/2024 - 12/2021
2cabazitaxelFDA Link
04/2024 - 01/2021
2Matrix Metalloproteinases (MMPs)IBA
02/2024 - 10/2020
2Aldehyde Reductase (Aldose Reductase)IBA
02/2024 - 01/2020
2Singlet OxygenIBA
12/2023 - 10/2021
2CytokinesIBA
10/2023 - 01/2022
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2023 - 08/2022
2Fatty Acids (Saturated Fatty Acids)IBA
01/2023 - 01/2016
2HydrogelsIBA
01/2023 - 01/2019
2Immunologic Adjuvants (Immunologic Adjuvant)IBA
01/2023 - 01/2023
2Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2023 - 01/2022
2130-nm albumin-bound paclitaxelIBA
12/2022 - 11/2009
2AnthracyclinesIBA
12/2022 - 10/2021
2Anti-Bacterial Agents (Antibiotics)IBA
12/2022 - 04/2022
2Drug CarriersIBA
12/2022 - 11/2009
2Cancer VaccinesIBA
11/2022 - 03/2022
2Oxygen (Dioxygen)IBA
08/2022 - 08/2020
2Peptides (Polypeptides)IBA
02/2022 - 01/2022
2shikoninIBA
01/2022 - 10/2021
2Coordination ComplexesIBA
01/2022 - 02/2021

Therapy/Procedure

95Therapeutics
05/2024 - 09/2010
30Drug Therapy (Chemotherapy)
01/2023 - 10/2012
20Immunotherapy
12/2023 - 01/2021
15Photochemotherapy (Photodynamic Therapy)
12/2023 - 06/2018
7Precision Medicine
10/2023 - 12/2014
7Phototherapy (Light Therapy)
01/2023 - 09/2018
7Lasers (Laser)
01/2023 - 11/2018
3Photothermal Therapy
04/2024 - 01/2019
3Combination Drug Therapy (Combination Chemotherapy)
01/2022 - 11/2009
3Intravenous Administration
07/2021 - 02/2017
3Transdermal Patch
09/2010 - 12/2009
2Biological Therapy
09/2023 - 01/2021
2Radiotherapy
01/2022 - 01/2021
2Injections
01/2022 - 02/2021